Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn's Disease. | J Clin Med | 2023 | 37048779 | PubTator, text mining | PubMed |
| Consensus for criteria of running a pediatric inflammatory bowel disease center using a modified Delphi approach. | World J Pediatr | 2023 | 37022658 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
| Prevalence of Sarcopenia in Liver Cirrhosis: A Systematic Review and Meta-Analysis. | Clin Transl Gastroenterol | 2023 | 37011140 | PubTator, text mining | PubMed |
| Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases. | Pharmaceutics | 2023 | 36986830 | PubTator, text mining | PubMed |
| Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn's Disease. | Pharmaceuticals (Basel) | 2023 | 36986472 | PubTator, text mining | PubMed |
| Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol. | Medicina (Kaunas) | 2023 | 36984489 | PubTator, text mining | PubMed |
| Metoprolol and CYP2D6: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes. | J Pers Med | 2023 | 36983598 | PubTator, text mining | PubMed |
| Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study. | Cancers (Basel) | 2023 | 36980643 | PubTator, text mining | PubMed |
| Immunosuppressive Therapy of Biopsy-Proven, Virus-Negative, Autoimmune/Immune-Mediated Myocarditis-Focus on Azathioprine: A Review of Existing Evidence and Future Perspectives. | Biology (Basel) | 2023 | 36979048 | PubTator, text mining | PubMed |
| Target Class Profiling of Small-Molecule Methyltransferases. | ACS Chem Biol | 2023 | 36976909 | PubTator, text mining | PubMed |
| Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies. | World J Gastroenterol | 2023 | 36970587 | PubTator, text mining | PubMed |
| TPMT gene polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a healthy Venezuelan population. | Pharmacogenomics | 2023 | 36946340 | PubTator, text mining | PubMed |
| Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine-Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia. | Clin Pharmacol Ther | 2023 | 36932910 | PubTator, text mining | PubMed |
| Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. | Ther Drug Monit | 2023 | 36917731 | PubTator, text mining | PubMed |
| A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China. | J Clin Lab Anal | 2023 | 36916827 | PubTator, text mining | PubMed |
| Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. | Front Microbiol | 2023 | 36910207 | PubTator, text mining | PubMed |
| ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia. | Mediterr J Hematol Infect Dis | 2023 | 36908869 | PubTator, text mining | PubMed |
| Influence of Genetic Variations in miRNA and Genes Encoding Proteins in the miRNA Synthesis Complex on Toxicity of the Treatment of Pediatric B-Cell ALL in the Brazilian Amazon. | Int J Mol Sci | 2023 | 36901860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=18